Intracerebral metastases history and symptoms: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 17: Line 17:


[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Oncology]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Neurology]]
[[Category:Neurology]]

Revision as of 03:03, 24 August 2015

Intracerebral metastases Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Intracerebral Metastases from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Intracerebral metastases history and symptoms On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Intracerebral metastases history and symptoms

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Intracerebral metastases history and symptoms

CDC on Intracerebral metastases history and symptoms

Intracerebral metastases history and symptoms in the news

Blogs on Intracerebral metastases history and symptoms

Directions to Hospitals Treating Intracerebral metastases

Risk calculators and risk factors for Intracerebral metastases history and symptoms

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Clinical Presentation and Prognosis

These patients commonly present with headache, seizure, mental status changes, ataxia, nausea and vomiting and visual disturbances. However, 10% of these patients may be asymptomatic.

Patients with brain mets have a mean survival of one month without treatment. With treatment, survival improves, but it is still dismal. The mean age of survival is still less than one year.

References